174 related articles for article (PubMed ID: 11302744)
1. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.
Ohkura N; Kishi M; Tsukada T; Yamaguchi K
Biochem Biophys Res Commun; 2001 Apr; 282(5):1206-10. PubMed ID: 11302744
[TBL] [Abstract][Full Text] [Related]
2. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.
Yaguchi H; Ohkura N; Tsukada T; Yamaguchi K
J Biol Chem; 2002 Oct; 277(41):38197-204. PubMed ID: 12145286
[TBL] [Abstract][Full Text] [Related]
3. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
4. Menin interacts directly with the homeobox-containing protein Pem.
Lemmens IH; Forsberg L; Pannett AA; Meyen E; Piehl F; Turner JJ; Van de Ven WJ; Thakker RV; Larsson C; Kas K
Biochem Biophys Res Commun; 2001 Aug; 286(2):426-31. PubMed ID: 11500056
[TBL] [Abstract][Full Text] [Related]
5. MEN1 tumor-suppressor protein localizes to telomeres during meiosis.
Suphapeetiporn K; Greally JM; Walpita D; Ashley T; Bale AE
Genes Chromosomes Cancer; 2002 Sep; 35(1):81-5. PubMed ID: 12203793
[TBL] [Abstract][Full Text] [Related]
6. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
9. The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily.
Paravicini G; Steinmayr M; André E; Becker-André M
Biochem Biophys Res Commun; 1996 Oct; 227(1):82-7. PubMed ID: 8858107
[TBL] [Abstract][Full Text] [Related]
10. Six novel MEN1 gene mutations in sporadic parathyroid tumors.
Cetani F; Pardi E; Giovannetti A; Cerrai P; Borsari S; Vignali E; Picone A; Cianferotti L; Miccoli P; Pinchera A; Marcocci C
Hum Mutat; 2000 Nov; 16(5):445. PubMed ID: 11058905
[TBL] [Abstract][Full Text] [Related]
11. Stable overexpression of MEN1 suppresses tumorigenicity of RAS.
Kim YS; Burns AL; Goldsmith PK; Heppner C; Park SY; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
Oncogene; 1999 Oct; 18(43):5936-42. PubMed ID: 10557080
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia type 1: from bedside to benchside.
Yoshimoto K
J Med Invest; 2000 Aug; 47(3-4):108-17. PubMed ID: 11019489
[TBL] [Abstract][Full Text] [Related]
13. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of JunD missense mutants that lack menin binding.
Knapp JI; Heppner C; Hickman AB; Burns AL; Chandrasekharappa SC; Collins FS; Marx SJ; Spiegel AM; Agarwal SK
Oncogene; 2000 Sep; 19(41):4706-12. PubMed ID: 11032020
[TBL] [Abstract][Full Text] [Related]
15. Menin and its interacting proteins: elucidation of menin function.
Balogh K; Rácz K; Patócs A; Hunyady L
Trends Endocrinol Metab; 2006 Nov; 17(9):357-64. PubMed ID: 16997566
[TBL] [Abstract][Full Text] [Related]
16. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.
Heppner C; Bilimoria KY; Agarwal SK; Kester M; Whitty LJ; Guru SC; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ; Burns AL
Oncogene; 2001 Aug; 20(36):4917-25. PubMed ID: 11526476
[TBL] [Abstract][Full Text] [Related]
18. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
[TBL] [Abstract][Full Text] [Related]
19. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1.
Otsuki Y; Tanaka M; Yoshii S; Kawazoe N; Nakaya K; Sugimura H
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4385-90. PubMed ID: 11274357
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
